Skip to content

Study on combined intervention of traditional Chinese medicine in patients with coronary atherosclerosis

Clinical efficacy evaluation of Tongmai Zhuyu Decoction on patients with coronary heart disease with blood stasis syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000419
Enrollment
Unknown
Registered
2025-02-27
Start date
2025-02-20
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

Experimental group:On the basis of western medicine basic treatment plus Traditional Chinese Medicine Tongmai Zhuyu Decoction
CHD blood stasis group:Basic treatment of Western Medicine

Sponsors

Qingdao Traditional Chinese Medicine Hospital (Haici hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of coronary heart disease and blood stasis syndrome; 2. Age 35-75 years old gender unlimited; 3. Complete archives with repeated and traceable hospitalization records/outpatient records/flow records medication records follow-up records; 4. Participants who voluntarily participated in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cardiopulmonary dysfunction (NYHA =III) and severe arrhythmias including rapid atrial fibrillation atrial flutter paroxysmal ventricular tachycardia etc.; 2. Those who have taken Chinese medicine for promoting blood circulation and removing blood stasis in the past 2 weeks; 3. Systemic diseases with intrinsic inflammatory response (such as inflammatory bowel disease systemic lupus erythematosus etc.); 4. Vegetarians or people with irregular diet and serious eating behavior disorders; 5. Chronic anti-inflammatory therapy with steroids and/or non-steroidal anti-inflammatory drugs or prior antibiotic therapy within the past 3 months; 6. Uncontrolled alcohol or drug abusers. 7. Patients who have participated in other clinical trials within the last 3 months.

Design outcomes

Primary

MeasureTime frame
Blood microbial sequencing;

Secondary

MeasureTime frame
Blood biochemistry and other indicators;Blood cells and classification indicators;lymphocyte subsets detection;Evaluation of efficacy of traditional Chinese medicine syndrome;Evaluation of efficacy of traditional Chinese medicine syndrome;immune-inflammatory factors;

Countries

China

Contacts

Public ContactJiang Ting

Qingdao Traditional Chinese Medicine Hospital (Haici Hospital)

jiangting@qdu.edu.cn13730998269

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026